CA
NZ
UK
AU
IND
US
Prime Medicine (NASDAQ:PRME), a Cambridge, Massachusetts-based, pre-commercial biotechnology company pioneering one-time genetic therapies through its Prime Editing platform, is extending its advance in Wednesday's session, building on a rally sparked a day earlier when the company dosed its first patient in a global Phase …
Recursion Pharmaceuticals (NASDAQ:RXRX) shares are trading lower in Wednesday's session, giving back a portion of the gains from a roughly 13% rally earlier this month that had been driven by renewed enthusiasm around the company's artificial intelligence partnerships. Today's pullback comes alongside a broader …
Savara (NASDAQ:SVRA), a clinical-stage biopharmaceutical company, is trading higher in Wednesday's session on above-average volume as investors respond to renewed bullish coverage ahead of a November 22 FDA decision on its lead candidate. One research firm initiated coverage with a bullish rating, while another …
China SXT Pharmaceuticals (NASDAQ:SXTC), a specialty pharmaceutical company incorporated in 2005 and headquartered in Taizhou, Jiangsu Province, China, that focuses on Traditional Chinese Medicine Pieces, is trading sharply higher in Wednesday's session, climbing 280.00% on volume far exceeding its usual turnover. No press release, …
VERAXA Biotech AG (NASDAQ:VRXA), a Zurich-based oncology company developing antibody-based cancer therapies, is trading sharply higher in Wednesday's session after detailing how it is implementing FDA-aligned New Approach Methodologies across its preclinical research programs. The company said the approach could accelerate clinical advancement of …
Zenas BioPharma (NASDAQ:ZBIO) shares are trading higher in Wednesday's session, with investor attention building around a scheduled virtual research and development event on October 27 covering the company's lead autoimmune disease programs. Recent bullish commentary has also highlighted the company's regulatory progress, contributing to …
Published market data showed Jaguar Health (NASDAQ:JAGX) gaining 18.8% to USD 5.62 on October 6, 2026. We searched the company's recent releases and filings and found no announcement dated October 5 or 6, so the cause of the day's move is unverified. The shares …
Published market data showed Pacific Biosciences of California (NASDAQ:PACB) falling 5.9% to USD 2.70 on October 6, 2026. The move came alongside weakness in other genomics and biotech names, including Guardant Health and Caribou Biosciences, which points to sector pressure rather than a company …
AMN Healthcare announced second quarter 2026 results on August 6, 2026. Revenue of USD 673.2 million rose 2% from a year earlier.Net Incomewas USD 21.2 million, or USD 0.53 per diluted share on aGAAPbasis, and adjustedDiluted Earnings per Sharewere USD 0.77. Adjusted EBITDA of …
Aveanna Healthcare Holdings announced second quarter results and revised 2026 guidance on August 13, 2026. Revenue of USD 670.5 million was up 13.7% from USD 589.6 million a year earlier. Net income was USD 40.3 million versus USD 27.0 million, and adjusted EBITDA grew …
Please wait processing your request...